REACH Annex XVII, entry 71: 1-methyl-2-pyrrolidone (NMP)
Entry 71 covers: 1-methyl-2-pyrrolidone (NMP). The first condition begins: "1. Shall not be placed on the market as a substance on its own or in mixtures in a concentration equal to or greater than 0,3 % after 9 May 2020 unless manufacturers, importers and downstream users ..."
- Annex
- XVII: Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
- Entry number
- 71
- CAS numbers in the designation
- 872-50-4
- Version
- Consolidated version of 22 June 2026
- Official source
- Regulation (EC) No 1907/2006 (REACH), consolidated text
Designation of the substance, of the group of substances or of the mixture (official wording)
1-methyl-2-pyrrolidone
(NMP)
CAS No 872-50-4
EC No 212-828-1
Conditions of restriction (official wording)
1. Shall not be placed on the market as a substance on its own or in mixtures in a concentration equal to or greater than 0,3 % after 9 May 2020 unless manufacturers, importers and downstream users have included in the relevant chemical safety reports and safety data sheets, Derived No-Effect Levels (DNELs) relating to exposure of workers of 14,4 mg/m3 for exposure by inhalation and 4,8 mg/kg/day for dermal exposure.
2. Shall not be manufactured, or used, as a substance on its own or in mixtures in a concentration equal to or greater than 0,3 % after 9 May 2020 unless manufacturers and downstream users take the appropriate risk management measures and provide the appropriate operational conditions to ensure that exposure of workers is below the DNELs specified in paragraph 1.
3. By way of derogation from paragraphs 1 and 2, the obligations laid down therein shall apply from 9 May 2024 in relation to placing on the market for use, or use, as a solvent or reactant in the process of coating wires.
Neighbouring entries
Want Annex XVII by CAS or EC number?
If we publish an index of Annex XVII by CAS and EC number, we write to you once. We use the email for nothing else.